Medtronic (MDT) EV to EBITDA (2015 - 2026)

Medtronic has disclosed EV to EBITDA across 12 years of filings, most recently posting 14.9 for Q3 2026.

• In Q3 2026, EV to EBITDA fell 18.01% year-over-year to 14.9; the TTM figure through Jul 2026 stood at 14.9 (down 18.01% YoY), while the FY2026 annual figure was 15.16, down 8.94% from the prior year.
• EV to EBITDA came in at 14.9 for Q3 2026 at Medtronic, down from 15.16 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 22.41 in Q1 2022 to a low of 14.9 in Q3 2026.
• Average EV to EBITDA over 5 years is 18.57, with a median of 18.81 recorded in 2024.
• Year-over-year, EV to EBITDA plunged 47.17% in 2022 and surged 31.53% in 2024.
• Over 5 years, EV to EBITDA stood at 17.79 in 2022, then dropped by 14.34% to 15.24 in 2023, then jumped by 31.53% to 20.04 in 2024, then fell by 10.1% to 18.02 in 2025, then declined by 17.31% to 14.9 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 14.9 in Q3 2026, 15.16 in Q2 2026, and 20.11 in Q1 2026.